VMA21 Antikörper (N-Term)
Kurzübersicht für VMA21 Antikörper (N-Term) (ABIN205060)
Target
Alle VMA21 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- Human VMA21
-
Homologie
- Percent identity by BLAST analysis: Human (100%) Mouse, Rat, Rabbit (92%) Bovine (91%) Dog (85%).
-
Aufreinigung
- Protein A purified
-
Immunogen
-
Synthetic peptide from N-Terminus of human VMA21 (Q3ZAQ7, NP_001017980). Percent identity by BLAST analysis: Human, Chimpanzee, Orangutan, Gibbon, Monkey (100%), Marmoset, Mouse, Rat, Rabbit (92%), Bovine, Pig (91%), Hamster, Elephant, Panda, Dog (85%).
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Approved: IHC, IHC-P, WB (5 μg/mL)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- After adding water, will consist of PBS buffer with 2 % sucrose
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- VMA21 (Vacuolar H+-ATPase Homolog (VMA21))
-
Andere Bezeichnung
- VMA21 / XMEA
-
Hintergrund
-
Name/Gene ID: VMA21
Synonyms: VMA21, MEAX, XMEA -
Gen-ID
- 203547
-
NCBI Accession
- NP_001017980
-
UniProt
- Q3ZAQ7
Target
-